439 related articles for article (PubMed ID: 4136226)
21. Lymphocyte-derived chemotactic factor production by neonatal lymphocytes.
Keller MA; Kidd RM; Leake RD; Everett SL
Pediatr Res; 1983 Oct; 17(10):799-802. PubMed ID: 6356001
[TBL] [Abstract][Full Text] [Related]
22. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients.
Remold-O'Donnell E; Cooley J; Shcherbina A; Hagemann TL; Kwan SP; Kenney DM; Rosen FS
J Immunol; 1997 May; 158(9):4021-5. PubMed ID: 9126958
[TBL] [Abstract][Full Text] [Related]
23. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
Ward PA; Dvorak HF; Cohen S; Yoshida T; Data R; Selvaggio SS
J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
[TBL] [Abstract][Full Text] [Related]
24. Production of macrophage migration inhibitory factor and lymphotoxin by leukocytes from normal and Wiskott-Aldrich syndrome patients.
Oppenheim JJ; Blaese RM; Horton JE; Thor DE; Granger GA
Cell Immunol; 1973 Jul; 8(1):62-70. PubMed ID: 4581164
[No Abstract] [Full Text] [Related]
25. Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.
Snyderman R; Altman LC; Hausman MS; Mergenhagen SE
J Immunol; 1972 Mar; 108(3):857-60. PubMed ID: 5011759
[No Abstract] [Full Text] [Related]
26. Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes.
Altman LC; Chassy B; Mackler BF
J Immunol; 1975 Jul; 115(1):18-21. PubMed ID: 1097502
[TBL] [Abstract][Full Text] [Related]
27. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
28. Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP-Brucella abortus behaves as a T-independent type 1 antigen in humans.
Golding B; Muchmore AV; Blaese RM
J Immunol; 1984 Dec; 133(6):2966-71. PubMed ID: 6436369
[TBL] [Abstract][Full Text] [Related]
29. Wiskott-Aldrich syndrome: a disorder of haematopoietic cytoskeletal regulation.
Thrasher AJ; Burns S
Microsc Res Tech; 1999 Oct; 47(2):107-13. PubMed ID: 10523789
[TBL] [Abstract][Full Text] [Related]
30. Expansion of large granular lymphocyte subsets in Wiskott-Aldrich syndrome.
Plebani A; Airò P; Brugnoni D; Lebowitz M; Cattaneo R; Monafo V; Meini A; Notarangelo LD; Duse M; Ugazio AG
Haematologica; 1995; 80(6):521-5. PubMed ID: 8647517
[TBL] [Abstract][Full Text] [Related]
31. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
Lett-Brown MA; Boetcher DA; Leonard EJ
J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
[TBL] [Abstract][Full Text] [Related]
32. WASp in immune-system organization and function.
Thrasher AJ
Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
[TBL] [Abstract][Full Text] [Related]
33. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
34. Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome.
Henriquez NV; Rijkers GT; Zegers BJ
J Immunol; 1994 Jul; 153(1):395-9. PubMed ID: 7515927
[TBL] [Abstract][Full Text] [Related]
35. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
36. Update of the Wiskott-Aldrich syndrome. From a new case report.
Martín Mateos MA; Muñoz-López F; Cruz M
Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
Wahl SM; Altman LC; Rosenstreich DL
J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
[TBL] [Abstract][Full Text] [Related]
38. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp.
Jones GE; Zicha D; Dunn GA; Blundell M; Thrasher A
Int J Biochem Cell Biol; 2002 Jul; 34(7):806-15. PubMed ID: 11950596
[TBL] [Abstract][Full Text] [Related]
39. [Wiskott-Aldrich syndrome (literature review)].
Shabalov NP
Vopr Okhr Materin Det; 1975 Feb; 20(2):50-4. PubMed ID: 1094723
[No Abstract] [Full Text] [Related]
40. Evidence for antigenic selection of large granular lymphocytes in a patient with Wiskott-Aldrich syndrome.
Sottini A; Bettinardi A; Quiròs-Roldan E; Plebani A; Airò P; Primi D; Imberti L
Blood; 1995 Sep; 86(6):2240-7. PubMed ID: 7545024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
